Paclitaxel coated balloon

DEVICE4 trials

Sponsors

B. Braun Melsungen AG, InnoRa GmbH, Xijing Hospital, Singapore General Hospital

Conditions

Coronary Artery DiseaseCoronary RestenosisDe Novo StenosisDialysis Access MalfunctionNeointimal HyperplasiaRestenosisStenosis

Phase 3

Clinical Trial on Peripheral Arteries Treated With SeQuent® Please P Paclitaxel Coated Balloon Catheter

CompletedNCT01970579

B. Braun Melsungen AGRestenosis, Stenosis

Start: 2013-10-31End: 2019-12-31Updated: 2020-03-30

Unknown Phase

Treatment of Coronary In-stent Restenosis (ISR) by a Sirolimus Coated or a Paclitaxel Coated Balloon

CompletedNCT03242096

InnoRa GmbHCoronary Restenosis

Start: 2017-07-21End: 2021-01-31Updated: 2021-08-27

Paclitaxel-coated Balloon for Treatment of De-novo Non-complex Coronary Artery Lesions

Active, not recruitingNCT04561739

Xijing HospitalCoronary Artery Disease, De Novo Stenosis

Start: 2021-02-01End: 2027-05-05Updated: 2024-03-29

A Prospective, Randomized Controlled Trial of Stent Graft and Drug Coated Balloon Treatment for Recurrent Cephalic Arch Stenosis in Dysfunctional Arteriovenous-venous Fistula

Singapore General HospitalDialysis Access Malfunction, Neointimal Hyperplasia

Start: 2022-04-20End: 2024-04-30Target: 80Updated: 2022-05-04

Related Papers

Impact of pulse pressure on outcomes following treatment with drug-coated balloon vs. drug-eluting stents: insights from the REC-CAGEFREE I trial

European journal of medical research2026-03-30

Impact of sex on outcomes in patients treated with drug-coated balloons versus drug-eluting stents for de novo coronary artery lesions: Insights from the REC-CAGEFREE I trial.

2026-01-22

Impact of Chronic Kidney Disease on Outcomes With Drug-Coated Balloons Versus Drug-Eluting Stents: Insights From the REC-CAGEFREE I Trial.

2025-11-20

Drug-Coated Balloon Angioplasty vs Up-Front Stenting for De Novo CAD: 3-Year Follow-Up of REC-CAGEFREE I Trial.

2025-10-27

Drug-coated balloon angioplasty with rescue stenting versus intended stenting for the treatment of patients with de novo coronary artery lesions (REC-CAGEFREE I): an open-label, randomised, non-inferiority trial.

2024-09-0262 citations

Drug-coated balloon angioplasty with provisional stenting versus primary stenting for the treatment of de novo coronary artery lesions: REC-CAGEFREE I trial rationale and design

BMC Cardiovascular Disorders2024-06-246 citations

Combined Analysis of Two Parallel Randomized Trials of Sirolimus-Coated and Paclitaxel-Coated Balloons in Coronary In-Stent Restenosis Lesions

Circulation Cardiovascular Interventions2022-09-0146 citations

Two-Year Clinical Outcomes of the CONSEQUENT Trial: Can Femoropopliteal Lesions be Treated with Sustainable Clinical Results that are Economically Sound?

2018-03-2740 citations

Angiographic and Clinical Outcomes After Treatment of Femoro-Popliteal Lesions with a Novel Paclitaxel-Matrix-Coated Balloon Catheter.

2017-06-2837 citations